Page last updated: 2024-10-28

hydroxychloroquine and Xerophthalmia

hydroxychloroquine has been researched along with Xerophthalmia in 3 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Xerophthalmia: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.

Research Excerpts

ExcerptRelevanceReference
"Although renal tubular acidosis (RTA), secondary to autoimmune interstitial nephritis, develops in a large proportion of patients with Sjögren's syndrome (SS), most of the subjects are asymptomatic."1.33A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature. ( Celik, Y; Gerenli, M; Pamuk, ON; Soy, M, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rihl, M1
Ulbricht, K1
Schmidt, RE1
Witte, T1
Soy, M1
Pamuk, ON1
Gerenli, M1
Celik, Y1
de Winter, S1
van Buchem, MA1
Vermeer, MH1

Other Studies

3 other studies available for hydroxychloroquine and Xerophthalmia

ArticleYear
Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rheumatology (Oxford, England), 2009, Volume: 48, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Autoantibodies; Carrier Proteins; Female; Huma

2009
A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
    Rheumatology international, 2005, Volume: 26, Issue:1

    Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Diagnosis, Differential; Drug Therapy, Combina

2005
Annular erythema of Sjögren's syndrome.
    Lancet (London, England), 2006, May-13, Volume: 367, Issue:9522

    Topics: Adult; Dermatologic Agents; Erythema; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Syste

2006